Saint Joseph’s Health System has named Nicolas A.F.Chronos, MD, President, Saint Joseph’s Translational Research Institute. Dr. Chronos has served as chief medical and scientific officer at the Institute since 1999.
“Dr. Chronos’ leadership will help SJTRI expand and create new relationships with Atlanta’s growing biomedical leaders, scientists and sponsors,” says Kirk Wilson, president and CEO of Saint Joseph’s Health System. “And, he will continue his clinical work at Saint Joseph’s Hospital, translating new medical discoveries into patient treatments sooner for the betterment of all our patients.” Dr. Chronos also has joined the Medical Group of Saint Joseph’s and will have offices on the hospital’s Perimeter (I-285/400) campus, as well as continue to see patients in offices at Cowles Clinic in Lake Oconee. SJTRI is dedicated to integrating preclinical and clinical research to enhance the understanding of disease and translate discoveries into novel treatments for patients – the ‘bench to bedside’ continuum. Dr. Chronos oversees approximately 60 preclinical trials at SJTRI and 30 clinical trials at Saint Joseph’s Hospital.
Dr. Chronos received a Bachelors degree in Medicine and Surgery from the Royal Free Hospital School of Medicine in London in 1987. Following, he trained in cardiology and subsequently interventional cardiology under the direction of Professors Ulrich Sigwart and Anthony Rickards at the Royal Brompton National Heart and Lung Institute.
In 1992, he was awarded a British Heart Foundation International Fellowship and moved to the United States to continue his research in thrombosis and interventional cardiology at Emory University School of Medicine under the direction of Spencer B. King, III, M.D. He was named Director of Research at the Andreas Gruentzig Cardiovascular Center at Emory University Hospital in 1997. Dr. Chronos is a Fellow of the Royal College of Physicians (London), Fellow of the American College of Cardiology, and Fellow of the European Society of Cardiology, and Fellow of the American Heart Association. He has served on the Data Safety Monitoring Board (ClinTrials Research), NIRVANA (Boston Scientific), and SCORES (Scimed Life Systems).
He was named Co-National Principal Investigator with Professor Mike Simmons on the FIRST study, the largest human clinical trial of angiogenesis. Currently Dr. Chronos is conducting two large clinical trials that use autologous or umbilical cord stem cells to repair damaged cardiac muscle. Dr. Chronos has also served on the Steering Committees for various studies RFPMR (Boston Scientific), TARGET (Merck & Co., Inc.), and FIRST (Chiron Corporation). Dr. Chronos has published over 200 peer-reviewed papers. His publications include articles in the Journal of the American College of Cardiology, Circulation, Heart and European Journal of Cardiology. He is an editorial consultant to the New England Journal of Medicine, British Heart Journal, Clinical Science, the Journal of the American College of Cardiology, Circulation, Heart, Atherosclerosis, Catheterization and Cardiovascular Interventions, Stent, Thrombosis Research, Cardiovascular Radiation Medicine, Journal of Stem Cells and other distinguished peer reviewed journals.
For more information contact Lynn Peterson, marketing and media relations specialist, at 404-851-5849.
